We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Point-of-Care Immunoassay Analyzer on Display at AACC Annual Meeting

By LabMedica International staff writers
Posted on 02 Aug 2016
Image: The LABGEO IB10 chemistry analyzer (Photo courtesy of Samsung / Thermo Fisher Scientific).
Image: The LABGEO IB10 chemistry analyzer (Photo courtesy of Samsung / Thermo Fisher Scientific).
A small, simple to use basic immunoassay analyzer designed for point-of-care (POC) settings is available for inspection in the Thermo Fisher Scientific (Fremont, CA, USA) Booth 2145 at the 2016 AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA).

The Samsung LABGEO IB10 chemistry analyzer is the result of the partnership between Samsung (Suwon, South Korea) and Thermo Fisher Scientific.

The LABGEO IB10 is a small, simple to use basic immunoassay analyzer designed for POC settings. It was designed to measure TnI, D-Dimer, NT-proBNP, Myoglobulin, CK-MB, TSH, HCG, and PCT (Procalcitonin) within 20 minutes from a single use cartridge. Each cartridge includes calibration data, lot number, analyte listing, and expiration data.

The broad menu, short turn around time, and simplicity of the LABGEOIB10 make it ideal for satellite laboratories, physician offices, remote locations, and other settings where speed and convenience can improve productivity and patient compliance to treatment goals.

Related Links:
Thermo Fisher Scientific
AACC Annual Meeting & Clinical Lab Expo
Samsung
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
Pipette
Accumax Smart Series
Hemodynamic System Monitor
OptoMonitor

Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The enhanced collaboration builds upon the successful launch of the AmplideX Nanopore Carrier Plus Kit in March 2025 (Photo courtesy of Bio-Techne)

Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded its agreement with Oxford Nanopore Technologies (Oxford, UK) to broaden Bio-Techne's ability to develop a portfolio of genetic products on Oxford... Read more